Health Information
Health Education
Health EducationBusulfan 認識化療藥品Busulfan
2024/1/22Busulfan is an alkylating agent that exerts its anticancer activity by reacting with DNA and interfering with DNA replication and cell division. This stops the growth and spread of cancer cell in the body.
Cabazitaxel 認識化療藥品Cabazitaxel
2024/1/22Cabazitaxel is a synthetic analogue of taxane, a nature product derived from the needles of the European yew tree. This medicine inhibits the action of proteins called microtubules for cell division, thus stopping cancer cells from separating into two new cells, eventually causing cell death.
Carfilzomib 認識化療藥品Carfilzomib
2024/1/22Carfilzomib is a proteasome inhibitor. A proteasome is an enzyme that is responsible for breaking down proteins in cells. By blocking the action of proteasome, waste proteins build up in myeloma cells, and cause them to die.
Clofarabine 認識化療藥品Clofarabine
2024/1/22Clofarabine is classified as an anticancer antimetabolites. This medicine inhibits ribonucleotide reductase that is essential for the formation of DNA and RNA. This stops the growth of cancer cells, causing the cells to die.
Dactinomycin 認識化療藥品Dactinomycin
2024/1/22Dactinomycin is classified as an anticancer antibiotic. This medicine inhibits DNA and RNA synthesis, thus stopping cell replication and eventually cause cell death. This cell damage slows or stops the growth of cancer cells in the body.
Daratumumab 認識化療藥品Daratumumab
2024/1/22Darzalex® is a monoclonal antibody that targets to the protein called CD38, which is highly expressed on multiple myeloma cells. Once Darzalex® attaches to CD38, it induces rapid cell death and activates the immune system to destroy the myeloma cells.
Daunorubicin 認識化療藥品Daunorubicin
2024/1/22Daunorubicin is classified as an anthracyline antibiotic. This medicine inhibits DNA synthesis by producing DNA cross-links which halt cell replication and eventually cause cell death. This cell damage slows or stops the growth of cancer cells in the body.
Atezolizumab 認識化療藥品Atezolizumab
2024/1/22Atezolizumab is a monoclonal antibody that binds to PD-L1 (programmed cell death ligand 1) and blocks its interaction with PD-1 (programmed cell death 1 receptor).
Blinatumomab 認識化療藥品Blinatumomab
2024/1/22Blinatumomab is a bispecific T-cell receptor-engaging (BiTE) antibody that binds to CD19 expressed on B cells and CD3 expressed on T cells.
Epirubicin 認識化療藥品Epirubicin
2024/1/22Epirubicin is classified as an anthracyline antibiotic. This medicine inhibits DNA synthesis by producing DNA cross-links which halt cell replication and eventually cause cell death.